# Impact of Formulation on Ciprofloxacin Oral Absorption

> **NCT00992329** · PHASE1 · COMPLETED · sponsor: **University of Maryland, Baltimore** · enrollment: 16 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** ciprofloxacin

## Key facts

- **NCT ID:** NCT00992329
- **Lead sponsor:** University of Maryland, Baltimore
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-01
- **Primary completion:** 2013-11
- **Final completion:** 2013-11
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2020-11-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00992329

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00992329, "Impact of Formulation on Ciprofloxacin Oral Absorption". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00992329. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*